Pesquisa | Biblioteca Virtual em Saúde

1.

Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial.

Cohen, Calvin J; Andrade-Villanueva, Jaime; Clotet, Bonaventura; Fourie, Jan; Johnson, Margaret A; Ruxrungtham, Kiat; Wu, Hao; Zorrilla, Carmen; Crauwels, Herta; Rimsky, Laurence T; Vanveggel, Simon; Boven, Katia.

Lancet ; 378(9787): 229-37, 2011 Jul 16.

Artigo em Inglês | MEDLINE | ID: mdl-21763935

2.

Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial.

Molina, Jean-Michel; Cahn, Pedro; Grinsztejn, Beatriz; Lazzarin, Adriano; Mills, Anthony; Saag, Michael; Supparatpinyo, Khuanchai; Walmsley, Sharon; Crauwels, Herta; Rimsky, Laurence T; Vanveggel, Simon; Boven, Katia.

Lancet ; 378(9787): 238-46, 2011 Jul 16.

Artigo em Inglês | MEDLINE | ID: mdl-21763936

3.

Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials.

Nelson, Mark; Amaya, Gerardo; Clumeck, Nathan; Arns da Cunha, Clovis; Jayaweera, Dushyantha; Junod, Patrice; Li, Taisheng; Tebas, Pablo; Stevens, Marita; Buelens, Annemie; Vanveggel, Simon; Boven, Katia.

J Antimicrob Chemother ; 67(8): 2020-8, 2012 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-22532465

4.

TMC278, a next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI), active against wild-type and NNRTI-resistant HIV-1.

Azijn, Hilde; Tirry, Ilse; Vingerhoets, Johan; de Béthune, Marie-Pierre; Kraus, Guenter; Boven, Katia; Jochmans, Dirk; Van Craenenbroeck, Elke; Picchio, Gaston; Rimsky, Laurence T.

Antimicrob Agents Chemother ; 54(2): 718-27, 2010 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-19933797

5.

Anemia, blood loss, and blood transfusions in North American children in the intensive care unit.

Bateman, Scot T; Lacroix, Jacques; Boven, Katia; Forbes, Peter; Barton, Roger; Thomas, Neal J; Jacobs, Brian; Markovitz, Barry; Goldstein, Brahm; Hanson, James H; Li, H Agnes; Randolph, Adrienne G.

Am J Respir Crit Care Med ; 178(1): 26-33, 2008 Jul 01.

Artigo em Inglês | MEDLINE | ID: mdl-18420962

6.

Correction to: Evaluation of Cardiovascular Disease Risk in HIV1-Infected Patients Treated with Darunavir.

Opsomer, Magda; Dimitrova, Dessislava; Verspeelt, Johan; Purrington, Amy; Mehbob, Abdul; Chavers, Scott; Pai, Helen; Vanveggel, Simon; Luo, Donghan; Brown, Kimberley; Moecklinghoff, Christiane; Nettles, Richard E; Boven, Katia.

Drugs R D ; 18(3): 249-250, 2018 09.

Artigo em Inglês | MEDLINE | ID: mdl-30079430

7.

Evaluation of Cardiovascular Disease Risk in HIV-1-Infected Patients Treated with Darunavir.

Opsomer, Magda; Dimitrova, Dessislava; Verspeelt, Johan; Purrington, Amy; Mehbob, Abdul; Chavers, Scott; Pai, Helen; Vanveggel, Simon; Luo, Donghan; Brown, Kimberley; Moecklinghoff, Christiane; Nettles, Richard E; Boven, Katia.

Drugs R D ; 18(3): 199-210, 2018 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-29992490

8.

Reactions to Eprex's adverse reactions.

Sharma, Basant; Ryan, Mary H; Boven, Katia.

Nat Biotechnol ; 24(10): 1199-200; author reply 1200, 2006 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-17033648

9.

Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO).

Wohl, David A; Orkin, Chloe; Doroana, Manuela; Pilotto, José H; Sungkanuparph, Somnuek; Yeni, Patrick; Vanveggel, Simon; Deckx, Henri; Boven, Katia.

Antivir Ther ; 19(2): 191-200, 2014.

Artigo em Inglês | MEDLINE | ID: mdl-24430534

10.

Pre-existing mutations in the rilpivirine Phase III trials ECHO and THRIVE: prevalence and impact on virological response.

Vingerhoets, Johan; Rimsky, Laurence; Van Eygen, Veerle; Nijs, Steven; Vanveggel, Simon; Boven, Katia; Picchio, Gaston.

Antivir Ther ; 18(2): 253-6, 2013.

Artigo em Inglês | MEDLINE | ID: mdl-22951490

11.

96-Week resistance analyses of rilpivirine in treatment-naive, HIV-1-infected adults from the ECHO and THRIVE Phase III trials.

Rimsky, Laurence; Van Eygen, Veerle; Hoogstoel, Annemie; Stevens, Marita; Boven, Katia; Picchio, Gaston; Vingerhoets, Johan.

Antivir Ther ; 18(8): 967-77, 2013.

Artigo em Inglês | MEDLINE | ID: mdl-23714781

12.

Clinical perspective on drug-drug interactions with the non-nucleoside reverse transcriptase inhibitor rilpivirine.

Crauwels, Herta; van Heeswijk, Rolf P G; Stevens, Marita; Buelens, Annemie; Vanveggel, Simon; Boven, Katia; Hoetelmans, Richard.

AIDS Rev ; 15(2): 87-101, 2013.

Artigo em Inglês | MEDLINE | ID: mdl-23681436

13.

Impact of food and different meal types on the pharmacokinetics of rilpivirine.

Crauwels, Herta M; van Heeswijk, Rolf P G; Buelens, Annemie; Stevens, Marita; Boven, Katia; Hoetelmans, Richard M W.

J Clin Pharmacol ; 53(8): 834-40, 2013 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-23720136

14.

Week 96 efficacy and safety of rilpivirine in treatment-naive, HIV-1 patients in two Phase III randomized trials.

Cohen, Calvin J; Molina, Jean-Michel; Cassetti, Isabel; Chetchotisakd, Ploenchan; Lazzarin, Adriano; Orkin, Chloe; Rhame, Frank; Stellbrink, Hans-Jürgen; Li, Taisheng; Crauwels, Herta; Rimsky, Laurence; Vanveggel, Simon; Williams, Peter; Boven, Katia.

AIDS ; 27(6): 939-950, 2013 Mar 27.

Artigo em Inglês | MEDLINE | ID: mdl-23211772

15.

Genotypic and phenotypic characterization of HIV-1 isolates obtained from patients on rilpivirine therapy experiencing virologic failure in the phase 3 ECHO and THRIVE studies: 48-week analysis.

Rimsky, Laurence; Vingerhoets, Johan; Van Eygen, Veerle; Eron, Joseph; Clotet, Bonaventura; Hoogstoel, Annemie; Boven, Katia; Picchio, Gaston.

J Acquir Immune Defic Syndr ; 59(1): 39-46, 2012 Jan 01.

Artigo em Inglês | MEDLINE | ID: mdl-22067667

16.

Pharmacokinetics and short-term safety and tolerability of etravirine in treatment-experienced HIV-1-infected children and adolescents.

Königs, Christoph; Feiterna-Sperling, Cornelia; Esposito, Susanna; Viscoli, Claudio; Rosso, Raffaella; Kakuda, Thomas N; Leemans, Ruud; Peeters, Monika; Mack, Rebecca; Peeters, Ingeborg; Sinha, Rekha; Boven, Katia; Giaquinto, Carlo.

AIDS ; 26(4): 447-55, 2012 Feb 20.

Artigo em Inglês | MEDLINE | ID: mdl-22156961

17.

Long-term efficacy, safety, and tolerability of rilpivirine (RPV, TMC278) in HIV type 1-infected antiretroviral-naive patients: week 192 results from a phase IIb randomized trial.

Wilkin, Aimee; Pozniak, Anton L; Morales-Ramirez, Javier; Lupo, Sergio H; Santoscoy, Mario; Grinsztejn, Beatriz; Ruxrungtham, Kiat; Rimsky, Laurence T; Vanveggel, Simon; Boven, Katia.

AIDS Res Hum Retroviruses ; 28(5): 437-46, 2012 May.

Artigo em Inglês | MEDLINE | ID: mdl-21902621

18.

Efficacy and safety of rilpivirine (TMC278) versus efavirenz at 48 weeks in treatment-naive HIV-1-infected patients: pooled results from the phase 3 double-blind randomized ECHO and THRIVE Trials.

Cohen, Calvin J; Molina, Jean-Michel; Cahn, Pedro; Clotet, Bonaventura; Fourie, Jan; Grinsztejn, Beatriz; Wu, Hao; Johnson, Margaret A; Saag, Michael; Supparatpinyo, Khuanchai; Crauwels, Herta; Lefebvre, Eric; Rimsky, Laurence T; Vanveggel, Simon; Williams, Peter; Boven, Katia.

J Acquir Immune Defic Syndr ; 60(1): 33-42, 2012 May 01.

Artigo em Inglês | MEDLINE | ID: mdl-22343174

19.

Efficacy and safety of TMC278 in antiretroviral-naive HIV-1 patients: week 96 results of a phase IIb randomized trial.

Pozniak, Anton L; Morales-Ramirez, Javier; Katabira, Elly; Steyn, Dewald; Lupo, Sergio H; Santoscoy, Mario; Grinsztejn, Beatriz; Ruxrungtham, Kiat; Rimsky, Laurence T; Vanveggel, Simon; Boven, Katia.

AIDS ; 24(1): 55-65, 2010 Jan 02.

Artigo em Inglês | MEDLINE | ID: mdl-19926964

20.

Epoetin-associated pure red cell aplasia in patients with chronic kidney disease: solving the mystery.

Boven, Katia; Knight, John; Bader, Fred; Rossert, Jérome; Eckardt, Kai-Uwe; Casadevall, Nicole.

Nephrol Dial Transplant ; 20 Suppl 3: iii33-40, 2005 May.

Artigo em Inglês | MEDLINE | ID: mdl-15824129

Biblioteca Virtual em Saúde

Saúde Pública Brasil

Sua seleção (0)

Formato de exportação:

Exportar: